Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AnGes MG Inc Announces Positive Phase I Drug Test Result Co-Developed with Shionogi & Co., Ltd.


Monday, 22 Jul 2013 09:00pm EDT 

AnGes MG Inc Announces Positive Phase I Drug Test Result Co-Developed with Shionogi & Co., Ltd. 

Company Quote

2378.0
48.0 +2.06%
22 Aug 2014